Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0BXBTG
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
EDC-4
|
|||||
| Synonyms |
Extracellular drug conjugate-4; extracellular drug conjugate-4 (Centrose); EDC4; EDC 4
Click to Show/Hide
|
|||||
| Organization |
Centrose LLC
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
3
|
|||||
| Structure |
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Urokinase plasminogen activator surface receptor (PLAUR)
|
Antigen Info | ||||
| Payload Name |
Glycosylation scillarenin
|
Payload Info | ||||
| Linker Name |
CEN010-105
|
Linker Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.